ProPhase Labs, Inc (NASDAQ:PRPH) Q2 2022 Earnings Conference Call August 11, 2022 9:00 AM ET

Company Participants

Ted Karkus - Chairman & Chief Executive Officer

Conference Call Participants

Yi Chen - H.C. Wainwright

Dennis Waldman - Barrett Productions, LLC

Operator

Good morning, and welcome to the ProPhase Labs Second Quarter 2022 Financial Results and Corporate Update. [Operator Instructions] Please note this is event is being recorded.

I would now like to conference over to Ted Karkus, CEO and Chairman of the Board of ProPhase Labs. Please go ahead.

Ted Karkus

Thanks so much. Thank you all for joining me today before start, unfortunately have to read the forward-looking statement. I'll read it quickly. I think you all know what it is. Before we begin today's call, I want to advise everyone that today's call will contain forward-looking statements, including statements relating to our plan expectations, future performance and future events, including statements regarding projected financial results for the third quarter of 2022, our expectations regarding the COVID-19 pandemic, future waves of the pandemic and continued demand for diagnostic testing, purse of funding; our plans to grow our diagnostic business, and expand our lab services, and our plans to grow our genomics businesses, our plans to develop and live [indiscernible] and Equinor and our expectation regarding efficiency of our cash and working capital. These statements are subject to risks and uncertainties that could cause our actual results to differ materially from those suggested by the forward-looking statements. Additional information concerning factors that could cause our results to differ materially from these forward-looking statements are contained in the earnings release that we issued earlier today as well as in our public filings with the SEC. The company undertakes no obligation to publicly update and revise any forward look statements whether as a result of new information, future events or otherwise except to the extent required by applicable law. Finally, the conference call is being webcast. The webcast the link is available in the Investor Relations section of ProPhaseLabs.com. Thank you, Wendy, and Brussel our amazing securities attorney for putting together my forward-looking statement.

All right. Now that I have that away, welcome all, I really want to appreciate your joining, I really appreciate your support and interest in our company. It's always hard for me to gauge whether there are some new investors on the call and to what extent I should address them as opposed to our longer-term investors and analysts and so forth.